跳至主要内容
临床试验/JPRN-UMIN000008004
JPRN-UMIN000008004尚未招募未知

Analysis of efficacy and safety of tacrolimus extended-release formulation on prevention of rejection and GVHD in allo-HSCT patients - Efficacy and safety of tacrolimus extended-ralease formulation

Tokyo Women's Medical University0 个研究点目标入组 15 人开始时间: 2012年5月21日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. patients who had allergic reaction to tacrolimus 2. patients with the administration ofcyclosporin A or bosentan 3. patients with the administration of potassium-conserving diuretic 4. patients who are pregnant or have the possiblity of pregnancy

研究者

发起方
Tokyo Women's Medical University

相似试验

Analysis of efficacy and safety of tacrolimus... | 临床试验